Advertisement

Topics

Latest "Diagnostic Laboratories & Radiology" News Stories

14:18 EDT 18th July 2018 | BioPortfolio

Here are the most relevant search results for "Diagnostic Laboratories & Radiology" found in our extensive news archives from over 250 global news sources.

More Information about Diagnostic Laboratories & Radiology on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Diagnostic Laboratories & Radiology for you to read. Along with our medical data and news we also list Diagnostic Laboratories & Radiology Clinical Trials, which are updated daily. BioPortfolio also has a large database of Diagnostic Laboratories & Radiology Companies for you to search.

Showing "Diagnostic Laboratories Radiology" News Articles 1–25 of 4,800+

Wednesday 18th July 2018

Global Chromatography Reagent Market Segmented by Type, Bed Shape, Physical State of Mobile Phase, Separation Mechanism, EndUser Industry, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global chromatography reagent market has been estimated at USD 4.8 billion in 2016 and is projected to reach USD 7.82 billion by 2023. Chromatography is a separation technique that is used to separate solutes, by using chromatographic reagents. This technique is used in biochemical processes for the separation of chemical compounds and the development of pure drug components. In the petroleum ...


Global Biological Seed Treatment Segmented by Applications, Crop, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

Seed treatment can be defined as the application of chemical ingredients or biological organisms to the seed that enables in suppressing, controlling or repelling plant pathogens, insects, or other pests that attack seeds, seedlings or plants. Seed applied technologies such as inoculants, herbicide safeners, micronutrients, plant growth regulators, seed coatings and colorants, among others, can al...

Abbott Labs raises 2018 earnings forecast, shares hit record high

Abbott Laboratories raised its full-year earnings forecast and topped estimates for quarterly profit on Wednesday, powered by demand for its glucose monitoring device for diabetics and gains from its multibillion dollar acquisitions.


Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership

RENSSELAER, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated services, announced a strategic partnership.  Under the agreement terms, the two companies will combine resources to provide the global scientific community with access to premium custom model design an...

Merck Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology

Merck, a leading science and technology company, has announced that it has entered into an agreement with HistoCyte Laboratories Ltd, Tyne, U.K., to be the exclusive multinational distributor of the company’s portfolio of cell line reference products for immunohistochemistry and in situ hybridization....

Physicians’ Education Resource® Presents the 2018 New York Advanced Practice Collaborative

Leading experts in primary care will gather to discuss strategies to improve the patient-provider relationship Physicians’ Education Resource®, LLC (PER®), announces the 2018 New York Advanced Practice Collaborative to be held on September 15, 2018, at the Westin New York Grand Central in New York City. The conference will be co-chaired by Lawrence...

Enzo Biochem Reports Validation of Three High Quality, Low Cost Biomarkers for Detecting Cancers and Their Progression, Especially in Women’s Health Area

Enzo Biochem Inc. (NYSE:ENZ) today announced the validation of three clinically relevant, cost-efficient biomarker detection tests for charting the progression of various cancers, especially in the field of women’s health. These cost effective, high quality primary antibodies function with our full open system workflow and complement Enzo’s strategy of...

Clovis Oncology to Announce Second Quarter 2018 Financial Results and Host Webcast Conference Call on August 1

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2018 financial results on Wednesday, August 1, 2018, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss the company’s results in greater detail. The conference call is being w...

Alcala Labs First to Integrate Neoteryx’s VAMS™ Technology for Substance Abuse Monitoring

Dried blood samples replace urine monitoring for patients of alcohol and opioid addiction Neoteryx LLC, announced that it will supply its Volumetric Absorptive Microsampling (VAMS™) technology, in the form of the Mitra® microsampling device, to

Global Biosimilars Market Segmented by Product Class and Geography Growth, Trend and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global biosimilar market has been estimated at USD 3474.01 million in 2017. The market is expected to register a CAGR of 43.8% during the forecast period, 2018 to 2023. North America accounted for the largest market share, accounting for approximately 30% of the global market share in 2017, while AsiaPacific region was estimated to register the fastest CAGR through the forecast period, 2018202...

Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Board

Twyman Served as Senior Vice President at Janssen Pharmaceutical Research & Development, Overseeing Alzheimer’s Disease Therapeutics Roy Ervin Twyman, MD, PhD, an academic neurologist with nearly 20 years’ experience in neuroscience pharmaceutical drug development, will join the NeuroVision Imaging Inc. Board of Directors on July 20.

New strategy may lead to more accurate breast cancer diagnoses

A study in Molecular Oncology indicates that examining the protein and RNA in leftover materials from routine diagnostic tests for breast cancer may lead to more accurate diagnoses.

Upsher-Smith Launches Fully Substitutable Generic Version Of Sabril

News Vigadrone (vigabatrin) is indicated for the treatment of infantile spasms and refractory complex partial seizures when potential benefits outweigh the risk of permanent vision loss.

Abbott Laboratories 2018 Q2 - Results - Earnings Call Slides

Abbott Labs tops profit estimates, raises full-year earnings forecast

Abbott Laboratories raised its full-year earnings forecast and reported a quarterly profit that beat analysts' estimates, powered by higher sales across its businesses, including its top-earning medical device unit.

EUSA Pharma Announces Acquisition of Global Rights to SYLVANT® (siltuximab) from Janssen Sciences Ireland UC for $115 Million

- Acquisition significantly boosts EUSA Pharma’s presence as a global biopharmaceutical company in oncology and rare disease - SYLVANT® is the only FDA and EMA approved treatment for the rare disorder, idiopathic multicentric Castleman’s disease (iMCD) - Leverages EUSA Pharma’s commercial and medical expertise in rapidly advancing ...

Tuesday 17th July 2018

Study assesses increased growth of secondary imaging interpretations

A new Harvey L. Neiman Health Policy Institute study assesses the increased growth of secondary interpretations of diagnostic imaging examinations in the Medicare population.

Charles River Laboratories' Long-Term Story Is Still Intact

Study results may lead to improved diagnostics for breast cancer

(Wiley) A study in Molecular Oncology indicates that examining the protein and RNA in leftover materials from routine diagnostic tests for breast cancer may lead to more accurate diagnoses.

Breakthrough blood test to detect melanoma early

Australian researchers have developed what is claimed to be the world’s first blood test capable of detecting melanoma in its early stages — a breakthrough that is expected to save thousands of lives, as well as millions of dollars for the health system. Australia has the second-highest rate of melanoma in the world, with 14,000 new diagnoses and almost 2000 deaths each year. According to lea...

Global Biosimilars Market Segmented by Product Class and Geography Growth, Trend and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global biosimilar market has been estimated at USD 3474.01 million in 2017. The market is expected to register a CAGR of 43.8% during the forecast period, 2018 to 2023. North America accounted for the largest market share, accounting for approximately 30% of the global market share in 2017, while AsiaPacific region was estimated to register the fastest CAGR through the forecast period, 2018202...

Global Molecular Weight Marker Market Segmented by Type of Product, Application, Marker and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global molecular weight marker market has been estimated at USD 372.72 million in 2017. The market is expected to register a CAGR of 12% during the forecast period, 2018 to 2023. North America accounted for the largest market, accounting for around 35% of the global market share, while AsiaPacific was estimated to register the fastest CAGR through the forecast period, 20182023.RD InvestmentsOn...

Global Flavonoid Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The changing lifestyles of consumers and growing demand for beauty health supplements are expected to propel the flavonoids consumption. The global flavonoid market is expected to cross USD 1 billion by 2025. Changing consumer lifestyles and rising demand for beauty health supplements are expected to propel flavonoids consumption over the forecast period 20182023. Phenolic acids, flavonoids, sti...

Quidel to Hold Second Quarter 2018 Financial Results Conference Call on August 7, 2018

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report second quarter 2018 financial results after market close on Tuesday, August 7, 2018. Following the release of results, Douglas Bryant, president and chief executive officer, and Randy Ste...

Adlai Nortye licenses shelved Novartis compound buparlisib to develop combo cancer therapies

Adlai Nortye licensed exclusive worldwide development and commercialization rights to Novartis Pharma AG's buparlisib (BKM120...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks